Drug Database
ER

erismodegib

✓ Approved

Novartis AG · CHD7 · 辅助诊断

什么是 erismodegib?

erismodegib 是一种辅助诊断,由Novartis AG研发。该药已获批,用于治疗相关适应症,给药途径:Others。

药物档案

公司Novartis AG
药物类别辅助诊断
分子靶点CHD7
给药途径Others
状态Approved

作用机制

分子靶点

erismodegib 作用于 1 个分子靶点:

CHD7chromodomain helicase DNA binding protein 7 (IS3, HH5)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

erismodegib 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Neoplasms benign, malignant and unspecified (incl cysts and polyps)Uterine cancer✓ Approved

相关研究文献

PubMedJournal for nurses in professional development2026-11-18

From Diagnostic Error to Diagnostic Excellence: Building Diagnostic Competence Across the Health Care Team.

Griffith Patricia B PB, Park Chan W CW

When a diagnosis no longer fits the clinical picture, nurses often recognize the discrepancy first. This first column in a yearlong series explores diagnostic excellence as a shared team responsibility and highlights nurses' contributions to observation, information integration, communication, and advocacy throughout the diagnostic process. Drawing on current diagnostic safety initiatives, the article outlines opportunities for nursing professional development practitioners to strengthen diagnostic reasoning and team-based competencies that enhance patient safety and care quality.

PMID 43046290
阅读全文 →
PubMedVeterinary and comparative oncology2026-11-18

Diagnostic and Translational Challenges in Canine Endocrine and Neuroendocrine Neoplasms: A Comparative Pathology Perspective.

Mitze Stefanie S, Williams Jonathan J, Davison Lucy Jane LJ, Xia Dong D et al.

The recognition and detection of endocrine and neuroendocrine neoplasms (NENs) in dogs and humans is challenging. This is, in part, because some are non-functional, and where hormone hypersecretion occurs, it can lead to a great variety of clinical syndromes. Additionally, metastatic patterns vary according to the primary anatomical site, and the typically slow growth of many endocrine tumours/NENs may lead to underestimation of biological aggressiveness and misclassification as benign disease. In human medicine, diagnostic evaluation relies on a comprehensive, anatomical site-specific histopathologic framework, incorporating immunohistochemistry as formalised in the 2025 World Health Organisation classification of endocrine tumours/NENs. In contrast, veterinary diagnostic frameworks for canine endocrine tumours/NENs remain comparatively underdeveloped, with limited standardisation of terminology, grading systems, and validated cut-off values. This review aims to raise awareness of key diagnostic challenges associated with the most clinically prevalent canine endocrine tumours/NENs: insulinoma, phaeochromocytoma and cortisol-producing adrenocortical tumours. Emphasis is placed on histopathological characterisation using immunohistochemistry, drawing parallels with established human diagnostic algorithms where appropriate. By synthesising current knowledge from human and canine pathology, this review highlights critical gaps in veterinary diagnostic practice and identifies opportunities for harmonisation of classification strategies. The development of standardised diagnostic guidelines has the potential not only to improve clinical management of affected dogs but also to strengthen the translational value of spontaneous canine endocrine tumours/NENs within the field of comparative oncology and One Medicine.

PMID 43046768
阅读全文 →
PubMedNeuro-oncology practice2026-11-18

Machine learning models for predicting pseudoprogression in glioblastoma: A systematic review and diagnostic meta-analysis.

Kotochinsky Martin M, Silva Yasmin Picanco YP, Goyal Abhishek A, Łajczak Paweł P et al.

Artificial intelligence and machine learning (ML) are increasingly being used in medical practice, particularly in neuroradiology. Glioblastoma, a highly aggressive brain tumor, poses significant diagnostic challenges, especially in differentiating actual tumor progression (TP) from pseudoprogression (PsP) using conventional magnetic resonance imaging (MRI). Machine learning and AI techniques offer a promising approach, but their diagnostic accuracy remains debated. A systematic review and diagnostic meta-analysis were performed to assess the diagnostic efficacy of ML algorithms applied in MRI of glioblastoma patients to differentiate between TP and PsP. We evaluated classical ML and deep learning models using diffusion-weighted, perfusion-weighted, and structural MRI inputs to differentiate PsP from true progression in glioblastoma. PubMed, Scopus, and Cochrane databases were searched. Pooled sensitivity, specificity, diagnostic odds ratio (DOR), accuracy, and area under the curve (AUC) were calculated using a random-effects model. Eleven studies involving a total of 676 patients were included. Machine learning models demonstrated a pooled sensitivity of 0.899 (95% CI, 0.843-0.936; I² = 16.3%) and a specificity of 0.766 (95% CI, 0.647-0.854; I² = 38.8%). The DOR was 27.059 (95% CI, 11.094-65.999; I² = 61.9%), and the overall accuracy was 0.85 (95% CI, 0.788-0.897; I² = 66%). The AUC was estimated at 0.88 (95% CI, 0.727-0.896). Deek's funnel plot showed no significant publication bias (P = .283). Machine learning-based models demonstrate high diagnostic accuracy in distinguishing TP from PsP in glioblastoma patients, offering a promising tool to enhance radiological assessment and support clinical decision-making. However, further standardization across algorithms and datasets is needed to facilitate their integration into routine clinical practice.

PMID 43047455
阅读全文 →
PubMedBMC oral health2026-11-18

Occlusion Chatterbox: an origami-inspired robotic device for enhancing dental occlusion training.

Motamedosanaye Vahideh V, Nikdelan Saeed S, Malekpour Parnia P, Safai Saeed S et al.

Occlusal morphology is a fundamental component of dental education and is essential for restorative, prosthodontic, and orthodontic procedures. However, traditional teaching methods-such as wax carving, plastic tooth models, and two-dimensional illustrations-often fail to provide learners with an interactive and spatially accurate understanding of occlusal features. We introduce the Occlusion Chatterbox, a novel origami-inspired robotic educational device designed to support the teaching and learning of dental occlusion. The device transforms the geometry of a traditional paper fortune teller (chatterbox) into a foldable structure representing occlusal surfaces. Each modular flap corresponds to a cusp or ridge and is actuated by stepper motors controlled via an ESP32-WROOM microcontroller. A programable LED system provides real-time color-coded guidance of the occlusal elements, synchronized with a companion Arduino-based software platform. A pilot study involving 23 third-year dental students compared the Occlusion Chatterbox with conventional instruction. Students trained with the device achieved significantly higher scientific assessment scores (7.45 ± 0.93 vs. 5.17 ± 1.99; p = 0.002) and reported greater satisfaction (43.18 ± 4.42 vs. 33.08 ± 6.02; p = 0.001), suggesting improved learning outcomes and student engagement. By combining tactile interaction, robotic articulation, and LED feedback, the Occlusion Chatterbox bridges the gap between the abstract concepts of occlusal morphology and concrete learner comprehension. It represents a low-cost, portable, and interactive alternative to static models and expensive virtual reality simulators, with the potential for broad adoption in preclinical dental curricula. To the best of our knowledge, this is the first reported origami-inspired robotic simulator specifically designed for teaching dental occlusion.

PMID 43046201
阅读全文 →
PubMedResearch and reports in urology2026-11-18

Diagnostic Evaluation of Automated Urine Particle Digital Imaging Device for Urinary Tract Infection Stewardship: A Cross-Sectional Laboratory-Based Study in Single Indonesian Tertiary Hospital.

Sugianli Adhi Kristianto AK, Fellani Fellani F, Rostini Tiene T

Urinary tract infections (UTIs) remain a significant global challenge where gold-standard cultures impose critical diagnostic delays. Rapid screening of UTIs is essential for antimicrobial stewardship programs to prevent empirical antibiotic overuse. This study evaluates the diagnostic accuracy of the UD-10 digital imaging system for bacteriuria detection compared to traditional culture. A prospective cross-sectional study at an Indonesian tertiary hospital (May-July 2024) analyzed 186 urine culture specimens, with screening threshold of >150 bacteria/µL as determined by UF-4000. The UD-10 utilized a charge-coupled device camera with objective lens to capture digital images of unstained, uncentrifuged urine. Performance was assessed via sensitivity (Sn), specificity (Sp), positive predictive value (PPV), negative predictive value (NPV), accuracy (ACC), and Cohen's kappa (k). These parameters provided the framework for evaluating the clinical utility of automated digital imaging. Culture positivity was 65.1%, with Gram-negative bacteria representing 89.8% of isolates, primarily Escherichia coli. The UD-10 demonstrated Sn of 80.9%, PPV of 83.1%, NPV of 66.2%, and ACC of 76.9% in predicting growth. Bacteriuria agreement was moderate with culture (k = 0.497) and these findings demonstrate the potential for enhanced diagnostic stewardship through rapid clinical intervention. Digital imaging of urine particles is a valuable tool for preliminary bacteriuria information in diagnostic stewardship. Incorporating this approach into a concept of UTIs diagnostic stewardship workflow-by offering an initial bacterial morphological classification-helps improve patient diagnosis and guide the use of empirical antibiotic based on local antibiogram guidance or clinical consensus within the healthcare setting.

PMID 43048134
阅读全文 →
PubMedEuropean journal of endocrinology2026-11-18

Diagnostic Performance of Biochemical Parameters to Diagnose Endogenous Hyperinsulinemic Hypoglycaemia.

Romberg Christina C, Hepprich Matthias M, Urwyler Sandrine A SA, Refardt Julie J et al.

The gold standard for diagnosing endogenous hyperinsulinemic hypoglycaemia (EHH) is the fasting test. The respective diagnostic value of insulin, C-peptide, proinsulin and beta-hydroxybutyrate levels in relation to glucose levels at the end of the fasting test remains ill-defined. We, therefore, aimed to explore the relevance of these parameters based on a literature review and individual data provided by different authors. Extensive literature research was conducted in the databases Embase and Medline to identify case reports and original studies that report data on the fasting test e.g. fasting duration, blood glucose and insulin levels at the end of the fast, as well as C-peptide, proinsulin and beta-hydroxybutyrate levels, where available. Histology after surgery was defined as the diagnostic gold standard for patients with positive fasting tests. Data on fasting tests of 522 individual patients and 36 individual controls were identified. Sensitivity and specificity of the fasting test were 75.7% [95%CI 71.8-79.2] and 94.4% [95%CI 81.9-98.5], respectively, in our cohort. Whereas blood glucose, insulin and C-peptide are measured and reported in most cases, proinsulin and beta-hydroxybutyrate were reported in only 51% and 50%, respectively. In relation to blood glucose levels, C-peptide concentrations reached higher diagnostic accuracy (AUC 0.97) than insulin (AUC 0.93). Meanwhile, proinsulin and beta-hydroxybutyrate had an even higher diagnostic accuracy (both AUC = 0.99). In our dataset, combined glucose and C-peptide showed a strong discriminatory performance for EHH. However, proinsulin and beta-hydroxybutyrate show the highest diagnostic accuracy for diagnosing EHH yet are not measured on a regular basis.

PMID 43046309
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多erismodegib